Lloyd T. Lam

11.4k total citations
39 papers, 3.2k citations indexed

About

Lloyd T. Lam is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lloyd T. Lam has authored 39 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Lloyd T. Lam's work include Cell death mechanisms and regulation (8 papers), NF-κB Signaling Pathways (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Lloyd T. Lam is often cited by papers focused on Cell death mechanisms and regulation (8 papers), NF-κB Signaling Pathways (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Lloyd T. Lam collaborates with scholars based in United States, United Kingdom and Germany. Lloyd T. Lam's co-authors include Louis M. Staudt, R. Eric Davis, Andreas Rosenwald, Georg Lenz, Lenny Dang, Elaine M. Hurt, Vu N. Ngo, Jena M. Giltnane, Laurence Lamy and Hong Zhao and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lloyd T. Lam

38 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lloyd T. Lam United States 22 1.9k 978 891 808 720 39 3.2k
Irene M. Pedersen United States 20 2.5k 1.4× 529 0.5× 1.0k 1.1× 341 0.4× 1.1k 1.5× 27 3.6k
François Sigaux France 30 1.8k 1.0× 954 1.0× 1.1k 1.2× 470 0.6× 382 0.5× 76 3.8k
Vivian Ruvolo United States 36 2.9k 1.6× 1.6k 1.6× 748 0.8× 363 0.4× 448 0.6× 153 4.7k
Betty Lamothe United States 25 2.5k 1.3× 811 0.8× 1.3k 1.4× 204 0.3× 1.3k 1.8× 32 3.8k
Catherine Pellat‐Deceunynck France 36 1.9k 1.0× 1.2k 1.3× 1.3k 1.4× 489 0.6× 236 0.3× 98 3.7k
Hilmar Quentmeier Germany 34 1.6k 0.9× 629 0.6× 684 0.8× 340 0.4× 316 0.4× 101 3.3k
Eric S. Martin United States 24 1.6k 0.8× 578 0.6× 502 0.6× 346 0.4× 386 0.5× 57 2.7k
Laurence Lamy United States 14 1.3k 0.7× 487 0.5× 679 0.8× 319 0.4× 337 0.5× 20 2.1k
Chris Saris United States 19 1.5k 0.8× 926 0.9× 881 1.0× 632 0.8× 224 0.3× 25 3.3k
Takaomi Sanda Singapore 35 3.1k 1.7× 1.0k 1.1× 767 0.9× 315 0.4× 849 1.2× 108 4.5k

Countries citing papers authored by Lloyd T. Lam

Since Specialization
Citations

This map shows the geographic impact of Lloyd T. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd T. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd T. Lam more than expected).

Fields of papers citing papers by Lloyd T. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd T. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd T. Lam. The network helps show where Lloyd T. Lam may publish in the future.

Co-authorship network of co-authors of Lloyd T. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd T. Lam. A scholar is included among the top collaborators of Lloyd T. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd T. Lam. Lloyd T. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phillips, Darren C., Cory Alvey, Justin P. Ingram, et al.. (2024). Abbv-453: A Highly Potent and Selective Next Generation Small Molecule Inhibitor of BCL-2. Blood. 144(Supplement 1). 4966–4966. 1 indexed citations
2.
Plotnik, Joshua P., Irene Lee, Jacob Riehm, et al.. (2024). MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer. Molecular Cancer Research. 22(8). 689–698.
3.
Wang, Rui, Yupeng He, Ziping Yang, et al.. (2018). Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP. Molecular Cancer Therapeutics. 17(12). 2543–2550. 46 indexed citations
4.
Lam, Lloyd T., Xiaoyu Lin, Emily J. Faivre, et al.. (2017). Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors. Molecular Cancer Therapeutics. 16(8). 1511–1520. 55 indexed citations
5.
Roberts, Andrew W., Tu Xu, Jia Jia, et al.. (2017). Do Statins Enhance the Anti-Cancer Activity of Venetoclax?. Blood. 130. 1737–1737. 1 indexed citations
6.
Guo, Jun, Lloyd T. Lam, Kenton L. Longenecker, et al.. (2017). Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD+ biosynthesis pathway and NAMPT mutation. Biochemical and Biophysical Research Communications. 491(3). 681–686. 27 indexed citations
7.
Tahir, Stephen K., Morey L. Smith, Paul Hessler, et al.. (2017). Potential mechanisms of resistance to venetoclax and strategies to circumvent it. BMC Cancer. 17(1). 399–399. 142 indexed citations
8.
Lam, Lloyd T., Haichao Zhang, John Xue, Joel Johansson, & Anahita Bhathena. (2015). Antihelminthic benzimidazoles potentiate navitoclax (ABT-263) activity by inducing Noxa-dependent apoptosis in non-small cell lung cancer (NSCLC) cell lines. Cancer Cell International. 15(1). 5–5. 11 indexed citations
9.
Zhang, Haichao, John Xue, Paul Hessler, et al.. (2015). Genomic analysis and selective small molecule inhibition identifies BCL-XL as a critical survival factor in a subset of colorectal cancer. Molecular Cancer. 14(1). 126–126. 43 indexed citations
10.
Phillips, Darren C., et al.. (2015). Loss in MCL-1 function sensitizes non-Hodgkin’s lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199). Blood Cancer Journal. 5(11). e368–e368. 94 indexed citations
11.
Lam, Lloyd T. & Lisa Roberts-Rapp. (2014). Multiplex Analysis of Anti-Apoptotic BCL2 Family and Caspase 3 Activation by Microbead Arrays. Assay and Drug Development Technologies. 12(3). 190–196. 5 indexed citations
12.
Lam, Lloyd T., Xin Lü, Haichao Zhang, et al.. (2010). A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax). Molecular Cancer Therapeutics. 9(11). 2943–2950. 44 indexed citations
13.
Wan, Fengyi, Darrell E. Anderson, R. Anthony Barnitz, et al.. (2007). Ribosomal Protein S3: A KH Domain Subunit in NF-κB Complexes that Mediates Selective Gene Regulation. Cell. 131(5). 927–939. 283 indexed citations
14.
Ngo, Vu N., R. Eric Davis, Laurence Lamy, et al.. (2006). A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 441(7089). 106–110. 455 indexed citations
15.
Kovanen, Panu E., Andreas Rosenwald, Elaine M. Hurt, et al.. (2003). Analysis of γc-Family Cytokine Target Genes. Journal of Biological Chemistry. 278(7). 5205–5213. 79 indexed citations
16.
Lam, Lloyd T., Oxana K. Pickeral, A Peng, et al.. (2001). Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome biology. 2(10). RESEARCH0041–RESEARCH0041. 315 indexed citations
17.
Lam, Lloyd T., Chiara Ronchini, Jason E. Norton, Anthony J. Capobianco, & Emery H. Bresnick. (2000). Suppression of Erythroid but Not Megakaryocytic Differentiation of Human K562 Erythroleukemic Cells by Notch-1. Journal of Biological Chemistry. 275(26). 19676–19684. 78 indexed citations
18.
Lam, Lloyd T. & Emery H. Bresnick. (1998). Identity of the β-Globin Locus Control Region Binding Protein HS2NF5 as the Mammalian Homolog of the Notch-regulated Transcription Factor Suppressor of Hairless. Journal of Biological Chemistry. 273(37). 24223–24231. 26 indexed citations
19.
Morgan, Kevin, Lloyd T. Lam, & Noor Kalsheker. (1996). A rapid and efficient method for DNA extraction from paraffin wax embedded tissue for PCR amplification. Molecular Pathology. 49(3). M179–M180. 8 indexed citations
20.
Lam, Lloyd T. & Emery H. Bresnick. (1995). Evidence for Distinct DNA Binding Forms of the Erythroid-Specific Transcription Factor NF-E2. Biochemistry. 34(50). 16347–16358. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene M. Pedersen Breakdown of academic impact, for papers by François Sigaux Breakdown of academic impact, for papers by Vivian Ruvolo Breakdown of academic impact, for papers by Betty Lamothe Breakdown of academic impact, for papers by Catherine Pellat‐Deceunynck Breakdown of academic impact, for papers by Hilmar Quentmeier Breakdown of academic impact, for papers by Eric S. Martin Breakdown of academic impact, for papers by Laurence Lamy Breakdown of academic impact, for papers by Chris Saris Breakdown of academic impact, for papers by Takaomi Sanda
Rankless by CCL
2026